22
Participants
Start Date
July 31, 2023
Primary Completion Date
September 18, 2024
Study Completion Date
September 18, 2024
BSI-045B
Patients will be treated with BSI-045B.
Sadick Research Group, New York
Paddington Testing Company, Philadelphia
The George Washington University School of Medicine and Health Science, Washington D.C.
Accellacare - Cary, Cary
Accellacare - Raleigh, Raleigh
Accellacare-Wilmington, Wilmington
Advanced Medical Research - Medical Dermatology Specialists, Sandy Springs
Skin Sciences/Derm Research Pllc., Louisville
Wright State Physicians Health Center, Fairborn
Dawes Fretzin Clinical Research, Indianapolis
Center for Clinical Studies - Webster, Webster
Profound Research LLC - Nashville - Corporate, Oceanside
First OC Dermatology - Fountain Valley, Fountain Valley
Center for Dermatology Clinical Research, Fremont
Dermatology Specialists of Spokane, Spokane
Allcutis Research - Beverly, MA, Beverly
Beacon Clinical Research, Quincy
Lead Sponsor
Biosion, Inc.
INDUSTRY